+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Colorectal Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Colorectal Cancer Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Diagnostic Imaging Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Diagnostic Imaging Collaboration and Licensing Deals 2016-2024

  • Report
  • November 2024
  • 350 Pages
  • Global
From
From
Autoimmune Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 500 Pages +
  • Global
From
From
Biologics Market Report 2024-2034 - Product Thumbnail Image

Biologics Market Report 2024-2034

  • Report
  • November 2023
  • 312 Pages
  • Global
From
From
From
From
Nasal Drug Delivery Technology Global Market Report 2024 - Product Thumbnail Image

Nasal Drug Delivery Technology Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Loading Indicator